Biotech Medics Ne Stock Return On Equity
| BMCS Stock | USD 0.01 0 14.29% |
Biotech Medics Ne fundamentals help investors to digest information that contributes to Biotech Medics' financial success or failures. It also enables traders to predict the movement of Biotech Pink Sheet. The fundamental analysis module provides a way to measure Biotech Medics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotech Medics pink sheet.
Biotech |
Biotech Medics Ne Company Return On Equity Analysis
Biotech Medics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Biotech Medics Ne has a Return On Equity of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
Biotech Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Medics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotech Medics could also be used in its relative valuation, which is a method of valuing Biotech Medics by comparing valuation metrics of similar companies.Biotech Medics is currently under evaluation in return on equity category among its peers.
Biotech Fundamentals
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 172.36 M | |||
| Price To Earning | (0.47) X | |||
| Price To Sales | 3.30 X | |||
| Revenue | 469.8 K | |||
| Gross Profit | 408.14 K | |||
| EBITDA | 33.35 K | |||
| Net Income | (603.72 K) | |||
| Cash And Equivalents | 1.31 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | 0.02 X | |||
| Earnings Per Share | (0) X | |||
| Beta | 3.5 | |||
| Market Capitalization | 870.4 K | |||
| Total Asset | 5.08 M | |||
| Retained Earnings | (1.75 M) | |||
| Working Capital | (1.98 M) | |||
| Current Asset | 27 K | |||
| Current Liabilities | 2.01 M | |||
| Net Asset | 5.08 M |
About Biotech Medics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Medics Ne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Medics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Medics Ne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.